Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that causes painful inflammation throughout the body. Cynthia Aranow, MD, professor in the Institute of Molecular Medicine, Lupus ...

Biogen Inc. recently reported 52-week Phase 2 results from the AMETHYST study of litifilimab in cutaneous lupus erythematosus ...

The Lupus Foundation of America is encouraging Tennesseans to get involved with the Tennessee Walk to End Lupus Now on ...

Phase 3 INDIGO open-label extension findings demonstrated sustained clinical activity of obexelimab –– Additional analyses of secondary ...

Commercial leader brings lupus nephritis and first-in-class launch experience as FT819 advances in the RECLAIM-LN Phase 2 trialProven record in ...

Heart disease remains the leading cause of death among women, and their cardiovascular risk begins to rise significantly ...

Biogen will release data from clinical trials for a few of its investigational treatments over the next few months, which should boost its shares, per JPMorgan.

A sushi meal sparked a medical crisis that left an influencer fighting for her life and experiencing paralysis affecting ...

A sample of your blood can reveal much about your health. But it can be hard to know which blood tests are truly worth taking ...

New data show favorable outcomes with subcutaneous infliximab following intravenous infliximab interruption, regardless of ...

Because kidney damage is difficult to reverse once it occurs, you should seek medical attention promptly when problems arise.

HanchorBio (TWSE: 7827) arrived at BioJapan 2026, held October 7–9 at PACIFICO Yokohama, with a partnering plan built in ...